Global Insomnia Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Pharmacological Therapy
1.2.3 Non-pharmacological Therapy
1.3 Market by Application
1.3.1 Global Insomnia Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Female
1.3.3 Male
1.3.4 Senior Citizens
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Insomnia Market Size (2017-2028)
2.2 Insomnia Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Insomnia Market Size by Region (2017-2022)
2.4 Global Insomnia Market Size Forecast by Region (2023-2028)
2.5 Global Top Insomnia Countries Ranking by Market Size
3 Insomnia Competitive by Company
3.1 Global Insomnia Revenue by Players
3.1.1 Global Insomnia Revenue by Players (2017-2022)
3.1.2 Global Insomnia Market Share by Players (2017-2022)
3.2 Global Insomnia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Insomnia Revenue
3.4 Global Insomnia Market Concentration Ratio
3.4.1 Global Insomnia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Revenue in 2021
3.5 Global Insomnia Key Players Head office and Area Served
3.6 Key Players Insomnia Product Solution and Service
3.7 Date of Enter into Insomnia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Insomnia Breakdown Data by Type
4.1 Global Insomnia Historic Revenue by Type (2017-2022)
4.2 Global Insomnia Forecasted Revenue by Type (2023-2028)
5 Global Insomnia Breakdown Data by Application
5.1 Global Insomnia Historic Market Size by Application (2017-2022)
5.2 Global Insomnia Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Insomnia Revenue by Company (2020-2022)
6.2 North America Insomnia Revenue by Type (2017-2028)
6.3 North America Insomnia Revenue by Application (2017-2028)
6.4 North America Insomnia Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Insomnia Revenue by Company (2020-2022)
7.2 Europe Insomnia Revenue by Type (2017-2028)
7.3 Europe Insomnia Revenue by Application (2017-2028)
7.4 Europe Insomnia Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Insomnia Revenue by Company (2020-2022)
8.2 Asia Pacific Insomnia Revenue by Type (2017-2028)
8.3 Asia Pacific Insomnia Revenue by Application (2017-2028)
8.4 Asia Pacific Insomnia Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Insomnia Revenue by Company (2020-2022)
9.2 Latin America Insomnia Revenue by Type (2017-2028)
9.3 Latin America Insomnia Revenue by Application (2017-2028)
9.4 Latin America Insomnia Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Insomnia Revenue by Company (2020-2022)
10.2 Middle East and Africa Insomnia Revenue by Type (2017-2028)
10.3 Middle East and Africa Insomnia Revenue by Application (2017-2028)
10.4 Middle East and Africa Insomnia Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Insomnia Products and Services
11.1.4 Merck Insomnia Revenue in Insomnia Business (2017-2022)
11.1.5 Merck Insomnia SWOT Analysis
11.1.6 Merck Recent Developments
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Eisai Business Overview
11.2.3 Eisai Insomnia Products and Services
11.2.4 Eisai Insomnia Revenue in Insomnia Business (2017-2022)
11.2.5 Eisai Insomnia SWOT Analysis
11.2.6 Eisai Recent Developments
11.3 Meda Consumer Healthcare
11.3.1 Meda Consumer Healthcare Company Details
11.3.2 Meda Consumer Healthcare Business Overview
11.3.3 Meda Consumer Healthcare Insomnia Products and Services
11.3.4 Meda Consumer Healthcare Insomnia Revenue in Insomnia Business (2017-2022)
11.3.5 Meda Consumer Healthcare Insomnia SWOT Analysis
11.3.6 Meda Consumer Healthcare Recent Developments
11.4 Takeda Pharmaceuticals
11.4.1 Takeda Pharmaceuticals Company Details
11.4.2 Takeda Pharmaceuticals Business Overview
11.4.3 Takeda Pharmaceuticals Insomnia Products and Services
11.4.4 Takeda Pharmaceuticals Insomnia Revenue in Insomnia Business (2017-2022)
11.4.5 Takeda Pharmaceuticals Insomnia SWOT Analysis
11.4.6 Takeda Pharmaceuticals Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Insomnia Products and Services
11.5.4 Pfizer Insomnia Revenue in Insomnia Business (2017-2022)
11.5.5 Pfizer Insomnia SWOT Analysis
11.5.6 Pfizer Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Insomnia Products and Services
11.6.4 Sanofi Insomnia Revenue in Insomnia Business (2017-2022)
11.6.5 Sanofi Insomnia SWOT Analysis
11.6.6 Sanofi Recent Developments
11.7 Vanda Pharmaceuticals
11.7.1 Vanda Pharmaceuticals Company Details
11.7.2 Vanda Pharmaceuticals Business Overview
11.7.3 Vanda Pharmaceuticals Insomnia Products and Services
11.7.4 Vanda Pharmaceuticals Insomnia Revenue in Insomnia Business (2017-2022)
11.7.5 Vanda Pharmaceuticals Insomnia SWOT Analysis
11.7.6 Vanda Pharmaceuticals Recent Developments
11.8 Pernix Therapeutics
11.8.1 Pernix Therapeutics Company Details
11.8.2 Pernix Therapeutics Business Overview
11.8.3 Pernix Therapeutics Insomnia Products and Services
11.8.4 Pernix Therapeutics Insomnia Revenue in Insomnia Business (2017-2022)
11.8.5 Pernix Therapeutics Insomnia SWOT Analysis
11.8.6 Pernix Therapeutics Recent Developments
11.9 Purdue Pharmaceuticals
11.9.1 Purdue Pharmaceuticals Company Details
11.9.2 Purdue Pharmaceuticals Business Overview
11.9.3 Purdue Pharmaceuticals Insomnia Products and Services
11.9.4 Purdue Pharmaceuticals Insomnia Revenue in Insomnia Business (2017-2022)
11.9.5 Purdue Pharmaceuticals Insomnia SWOT Analysis
11.9.6 Purdue Pharmaceuticals Recent Developments
12 Insomnia Market Dynamics
12.1 Insomnia Market Trends
12.2 Insomnia Market Drivers
12.3 Insomnia Market Challenges
12.4 Insomnia Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of TablesTable 1. Global Insomnia Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Pharmacological Therapy
Table 3. Key Players of Non-pharmacological Therapy
Table 4. Global Insomnia Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Insomnia Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Insomnia Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Insomnia Revenue Market Share by Region (2017-2022)
Table 8. Global Insomnia Revenue by Players (2017-2022) & (US$ Million)
Table 9. Global Insomnia Market Share by Players (2017-2022)
Table 10. Global Top Insomnia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia as of 2021)
Table 11. Ranking of Global Top Insomnia Companies by Revenue (US$ Million) in 2021
Table 12. Global 5 Largest Players Market Share by Insomnia Revenue (CR5 and HHI) & (2017-2022)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Insomnia Product Solution and Service
Table 15. Date of Key Manufacturers Enter into Insomnia Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Insomnia Market Size by Type (2017-2022) & (US$ Million)
Table 18. Global Insomnia Revenue Market Share by Type (2017-2022)
Table 19. Global Insomnia Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 20. Global Insomnia Revenue Market Share by Type (2023-2028)
Table 21. Global Insomnia Market Size by Application (2017-2022) & (US$ Million)
Table 22. Global Insomnia Revenue Market Share by Application (2017-2022)
Table 23. Global Insomnia Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 24. Global Insomnia Revenue Market Share by Application (2023-2028)
Table 25. North America Insomnia Revenue by Company (2020-2022) & (US$ Million)
Table 26. North America Insomnia Revenue by Type (2017-2022) & (US$ Million)
Table 27. North America Insomnia Revenue by Type (2023-2028) & (US$ Million)
Table 28. North America Insomnia Revenue by Application (2017-2022) & (US$ Million)
Table 29. North America Insomnia Revenue by Application (2023-2028) & (US$ Million)
Table 30. North America Insomnia Revenue by Country (2017-2022) & (US$ Million)
Table 31. North America Insomnia Revenue by Country (2023-2028) & (US$ Million)
Table 32. Europe Insomnia Revenue by Company (2020-2022) & (US$ Million)
Table 33. Europe Insomnia Revenue by Type (2017-2022) & (US$ Million)
Table 34. Europe Insomnia Revenue by Type (2023-2028) & (US$ Million)
Table 35. Europe Insomnia Revenue by Application (2017-2022) & (US$ Million)
Table 36. Europe Insomnia Revenue by Application (2023-2028) & (US$ Million)
Table 37. Europe Insomnia Revenue by Country (2017-2022) & (US$ Million)
Table 38. Europe Insomnia Revenue by Country (2023-2028) & (US$ Million)
Table 39. Asia Pacific Insomnia Revenue by Company (2020-2022) & (US$ Million)
Table 40. Asia Pacific Insomnia Revenue by Type (2017-2022) & (US$ Million)
Table 41. Asia Pacific Insomnia Revenue by Type (2023-2028) & (US$ Million)
Table 42. Asia Pacific Insomnia Revenue by Application (2017-2022) & (US$ Million)
Table 43. Asia Pacific Insomnia Revenue by Application (2023-2028) & (US$ Million)
Table 44. Asia Pacific Insomnia Revenue by Region (2017-2022) & (US$ Million)
Table 45. Asia Pacific Insomnia Revenue by Region (2023-2028) & (US$ Million)
Table 46. Latin America Insomnia Revenue by Company (2020-2022) & (US$ Million)
Table 47. Latin America Insomnia Revenue by Type (2017-2022) & (US$ Million)
Table 48. Latin America Insomnia Revenue by Type (2023-2028) & (US$ Million)
Table 49. Latin America Insomnia Revenue by Application (2017-2022) & (US$ Million)
Table 50. Latin America Insomnia Revenue by Application (2023-2028) & (US$ Million)
Table 51. Latin America Insomnia Revenue by Country (2017-2022) & (US$ Million)
Table 52. Latin America Insomnia Revenue by Country (2023-2028) & (US$ Million)
Table 53. Middle East and Africa Insomnia Revenue by Company (2020-2022) & (US$ Million)
Table 54. Middle East and Africa Insomnia Revenue by Type (2017-2022) & (US$ Million)
Table 55. Middle East and Africa Insomnia Revenue by Type (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Insomnia Revenue by Application (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Insomnia Revenue by Application (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Insomnia Revenue by Country (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Insomnia Revenue by Country (2023-2028) & (US$ Million)
Table 60. Merck Company Details
Table 61. Merck Business Overview
Table 62. Merck Insomnia Product and Services
Table 63. Merck Insomnia Revenue in Insomnia Business (2017-2022) & (US$ Million)
Table 64. Merck Insomnia SWOT Analysis
Table 65. Merck Recent Developments
Table 66. Eisai Company Details
Table 67. Eisai Business Overview
Table 68. Eisai Insomnia Product and Services
Table 69. Eisai Insomnia Revenue in Insomnia Business (2017-2022) & (US$ Million)
Table 70. Eisai Insomnia SWOT Analysis
Table 71. Eisai Recent Developments
Table 72. Meda Consumer Healthcare Company Details
Table 73. Meda Consumer Healthcare Business Overview
Table 74. Meda Consumer Healthcare Insomnia Product and Services
Table 75. Meda Consumer Healthcare Insomnia Revenue in Insomnia Business (2017-2022) & (US$ Million)
Table 76. Meda Consumer Healthcare Insomnia SWOT Analysis
Table 77. Meda Consumer Healthcare Recent Developments
Table 78. Takeda Pharmaceuticals Company Details
Table 79. Takeda Pharmaceuticals Business Overview
Table 80. Takeda Pharmaceuticals Insomnia Product and Services
Table 81. Takeda Pharmaceuticals Insomnia Revenue in Insomnia Business (2017-2022) & (US$ Million)
Table 82. Takeda Pharmaceuticals Insomnia SWOT Analysis
Table 83. Takeda Pharmaceuticals Recent Developments
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Insomnia Product and Services
Table 87. Pfizer Insomnia Revenue in Insomnia Business (2017-2022) & (US$ Million)
Table 88. Pfizer Insomnia SWOT Analysis
Table 89. Pfizer Recent Developments
Table 90. Sanofi Company Details
Table 91. Sanofi Business Overview
Table 92. Sanofi Insomnia Product and Services
Table 93. Sanofi Insomnia Revenue in Insomnia Business (2017-2022) & (US$ Million)
Table 94. Sanofi Insomnia SWOT Analysis
Table 95. Sanofi Recent Developments
Table 96. Vanda Pharmaceuticals Company Details
Table 97. Vanda Pharmaceuticals Business Overview
Table 98. Vanda Pharmaceuticals Insomnia Product and Services
Table 99. Vanda Pharmaceuticals Insomnia Revenue in Insomnia Business (2017-2022) & (US$ Million)
Table 100. Vanda Pharmaceuticals Insomnia SWOT Analysis
Table 101. Vanda Pharmaceuticals Recent Developments
Table 102. Pernix Therapeutics Company Details
Table 103. Pernix Therapeutics Business Overview
Table 104. Pernix Therapeutics Insomnia Product and Services
Table 105. Pernix Therapeutics Insomnia Revenue in Insomnia Business (2017-2022) & (US$ Million)
Table 106. Pernix Therapeutics Insomnia SWOT Analysis
Table 107. Pernix Therapeutics Recent Developments
Table 108. Purdue Pharmaceuticals Company Details
Table 109. Purdue Pharmaceuticals Business Overview
Table 110. Purdue Pharmaceuticals Insomnia Product and Services
Table 111. Purdue Pharmaceuticals Insomnia Revenue in Insomnia Business (2017-2022) & (US$ Million)
Table 112. Purdue Pharmaceuticals Insomnia SWOT Analysis
Table 113. Purdue Pharmaceuticals Recent Developments
Table 114. Insomnia Market Trends
Table 115. Insomnia Market Drivers
Table 116. Insomnia Market Challenges
Table 117. Insomnia Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Insomnia Sales Market Share by Type: 2021 VS 2028
Figure 2. Pharmacological Therapy Features
Figure 3. Non-pharmacological Therapy Features
Figure 4. Global Insomnia Sales Market Share by Application: 2021 VS 2028
Figure 5. Female Case Studies
Figure 6. Male Case Studies
Figure 7. Senior Citizens Case Studies
Figure 8. Insomnia Report Years Considered
Figure 9. Global Insomnia Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Insomnia Market Size 2017-2028 (US$ Million)
Figure 11. Global Insomnia Market Size Market Share by Region: 2021 VS 2028
Figure 12. Global Insomnia Revenue Market Share by Region in 2017 VS 2022
Figure 13. Global Top 10 Insomnia Countries Ranking by Market Size (US$ Million) in 2021
Figure 14. Global Insomnia Market Share by Players in 2021
Figure 15. Global Top Insomnia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Insomnia Revenue in 2021
Figure 17. North America Insomnia Revenue Market Share by Company in 2021
Figure 18. North America Insomnia Revenue Market Share by Type (2017-2028)
Figure 19. North America Insomnia Revenue Market Share by Application (2017-2028)
Figure 20. North America Insomnia Revenue Share by Country (2017-2028)
Figure 21. U.S. Insomnia Revenue (2017-2028) & (US$ Million)
Figure 22. Canada Insomnia Revenue (2017-2028) & (US$ Million)
Figure 23. Europe Insomnia Revenue Market Share by Company in 2021
Figure 24. Europe Insomnia Revenue Market Share by Type (2017-2028)
Figure 25. Europe Insomnia Revenue Market Share by Application (2017-2028)
Figure 26. Europe Insomnia Revenue Share by Country (2017-2028)
Figure 27. Germany Insomnia Revenue (2017-2028) & (US$ Million)
Figure 28. France Insomnia Revenue (2017-2028) & (US$ Million)
Figure 29. U.K. Insomnia Revenue (2017-2028) & (US$ Million)
Figure 30. Italy Insomnia Revenue (2017-2028) & (US$ Million)
Figure 31. Russia Insomnia Revenue (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Insomnia Revenue Market Share by Company in 2021
Figure 33. Asia Pacific Insomnia Revenue Market Share by Type (2017-2028)
Figure 34. Asia Pacific Insomnia Revenue Market Share by Application (2017-2028)
Figure 35. Asia Pacific Insomnia Revenue Share by Region (2017-2028)
Figure 36. China Insomnia Revenue (2017-2028) & (US$ Million)
Figure 37. Japan Insomnia Revenue (2017-2028) & (US$ Million)
Figure 38. South Korea Insomnia Revenue (2017-2028) & (US$ Million)
Figure 39. India Insomnia Revenue (2017-2028) & (US$ Million)
Figure 40. Australia Insomnia Revenue (2017-2028) & (US$ Million)
Figure 41. Taiwan Insomnia Revenue (2017-2028) & (US$ Million)
Figure 42. Indonesia Insomnia Revenue (2017-2028) & (US$ Million)
Figure 43. Thailand Insomnia Revenue (2017-2028) & (US$ Million)
Figure 44. Malaysia Insomnia Revenue (2017-2028) & (US$ Million)
Figure 45. Philippines Insomnia Revenue (2017-2028) & (US$ Million)
Figure 46. Vietnam Insomnia Revenue (2017-2028) & (US$ Million)
Figure 47. Latin America Insomnia Revenue Market Share by Company in 2021
Figure 48. Latin America Insomnia Revenue Market Share by Type (2017-2028)
Figure 49. Latin America Insomnia Revenue Market Share by Application (2017-2028)
Figure 50. Latin America Insomnia Revenue Share by Country (2017-2028)
Figure 51. Mexico Insomnia Revenue (2017-2028) & (US$ Million)
Figure 52. Brazil Insomnia Revenue (2017-2028) & (US$ Million)
Figure 53. Argentina Insomnia Revenue (2017-2028) & (US$ Million)
Figure 54. Middle East and Africa Insomnia Revenue Market Share by Company in 2021
Figure 55. Middle East and Africa Insomnia Revenue Market Share by Type (2017-2028)
Figure 56. Middle East and Africa Insomnia Revenue Market Share by Application (2017-2028)
Figure 57. Middle East and Africa Insomnia Revenue Share by Country (2017-2028)
Figure 58. Turkey Insomnia Revenue (2017-2028) & (US$ Million)
Figure 59. Saudi Arabia Insomnia Revenue (2017-2028) & (US$ Million)
Figure 60. U.A.E Insomnia Revenue (2017-2028) & (US$ Million)
Figure 61. Merck Revenue Growth Rate in Insomnia Business (2017-2022)
Figure 62. Eisai Revenue Growth Rate in Insomnia Business (2017-2022)
Figure 63. Meda Consumer Healthcare Revenue Growth Rate in Insomnia Business (2017-2022)
Figure 64. Takeda Pharmaceuticals Revenue Growth Rate in Insomnia Business (2017-2022)
Figure 65. Pfizer Revenue Growth Rate in Insomnia Business (2017-2022)
Figure 66. Sanofi Revenue Growth Rate in Insomnia Business (2017-2022)
Figure 67. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Business (2017-2022)
Figure 68. Pernix Therapeutics Revenue Growth Rate in Insomnia Business (2017-2022)
Figure 69. Purdue Pharmaceuticals Revenue Growth Rate in Insomnia Business (2017-2022)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed